已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas

易普利姆玛 无容量 癌症研究 免疫检查点 生物 表观遗传学 肿瘤微环境 肾透明细胞癌 转录组 表观遗传疗法 DNA甲基化 免疫疗法 舒尼替尼 免疫系统 癌症 医学 免疫学 内科学 肿瘤科 肾细胞癌 基因表达 基因 遗传学 肿瘤细胞
作者
Xiaofan Lu,Yann Vano,Alexandra Helleux,Xiaoping Su,Véronique Lindner,Guillaume Davidson,Roger Mouawad,Jean‐Philippe Spano,Morgan Rouprêt,Réza Elaidi,Éva Compérat,Virginie Verkarre,Cheng‐Ming Sun,Christine Chevreau,Mostefa Bennamoun,Hervé Lang,Thibault Tricard,Wenxuan Cheng,Li Xu,Irwin Davidson
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:29 (7): 1279-1291 被引量:10
标识
DOI:10.1158/1078-0432.ccr-22-2133
摘要

Abstract Purpose: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of patients with clear-cell renal cell carcinomas (ccRCC). Although analyses of transcriptome, genetic alterations, and the tumor microenvironment (TME) have shed light into mechanisms of response and resistance to these agents, the role of epigenetic alterations in this process remains fully unknown. Experimental Design: We investigated the methylome of six ccRCC cohorts as well as one cell line dataset. Of note, we took advantage of the BIONIKK trial aiming to tailor treatments according to Paris Descartes 4-gene expression subgroups, and performed Illumina EPIC profiling for 46 samples related to patients treated with ipilimumab plus nivolumab, and 17 samples related to patients treated with sunitinib. Results: A group of tumors associated with enhancer demethylation was discovered, namely TED. TED was associated with tumors with sarcomatoid differentiation and poor clinical outcome. TED harbored TET1 promoter demethylation, activated the gene expression signature of epithelial–mesenchymal transition and IL6/JAK/STAT3 pathways, and displayed a TME characterized by both immune activation and suppressive populations, fibroblast infiltration, and endothelial depletion. In addition, TED was a predictive factor of resistance to the combination of first-line ipilimumab-nivolumab in the BIONIKK clinical trial. Finally, TED was associated with activation of specific regulons, which we also found to be predictive of resistance to immunotherapy in an independent cohort. Conclusions: We report on the discovery of a novel epigenetic phenotype associated with resistance to ICIs that may pave the way to better personalizing patients’ treatments. See related commentary by Zhou and Kim, p. 1170
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
852的应助被wxyaaa采纳,获得10
刚刚
zgd完成签到 ,获得积分10
1秒前
1秒前
方远锋完成签到,获得积分10
2秒前
倾情清发布了新的文献求助10
2秒前
flyboy完成签到,获得积分10
2秒前
科研通AI65的应助被腼腆的立诚采纳,获得10
3秒前
852的应助被fyneru采纳,获得10
3秒前
Hello的应助被快乐的心情采纳,获得10
4秒前
zxy的应助被科研通管家采纳,获得10
5秒前
LEEHI的应助被科研通管家采纳,获得10
5秒前
伊伊完成签到 ,获得积分10
5秒前
LEEHI的应助被科研通管家采纳,获得10
5秒前
null的应助被科研通管家采纳,获得10
5秒前
5秒前
香蕉觅云的应助被科研通管家采纳,获得20
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
所所的应助被科研通管家采纳,获得10
5秒前
斯文败类的应助被科研通管家采纳,获得10
6秒前
阿三的应助被科研通管家采纳,获得30
6秒前
6秒前
桐桐的应助被科研通管家采纳,获得10
6秒前
6秒前
风吹麦浪的应助被科研通管家采纳,获得10
6秒前
传奇3的应助被初景采纳,获得10
6秒前
6秒前
6秒前
9秒前
Tanyang完成签到 ,获得积分10
10秒前
10秒前
10秒前
Maestro_S的应助被开心德地采纳,获得10
12秒前
夏小川完成签到,获得积分10
13秒前
所所的应助被宿雨采纳,获得10
13秒前
13秒前
14秒前
15秒前
青春梦完成签到 ,获得积分10
15秒前
qianzhihe发布了新的文献求助10
16秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184686
求助须知:如何正确求助?哪些是违规求助? 9573640
关于积分的说明 21832630
捐赠科研通 7782020
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558513
邀请新用户注册赠送积分活动 2481010